Exact Mass: 289.1704646

Exact Mass Matches: 289.1704646

Found 183 metabolites which its exact mass value is equals to given mass value 289.1704646, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Hyoscyamine

BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-, (3-ENDO)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER, (.ALPHA.S)-

C17H23NO3 (289.1677848)


(S)-atropine is an atropine with a 2S-configuration. It is functionally related to a (S)-tropic acid. It is a conjugate base of a (S)-atropinium. Hyoscyamine is a tropane alkaloid and the levo-isomer of [atropine]. It is commonly extracted from plants in the Solanaceae or nightshade family. Research into the action of hyoscyamine in published literature dates back to 1826. Hyoscyamine is used for a wide variety of treatments and therapeutics due to its antimuscarinic properties. Although hyoscyamine is marketed in the United States, it is not FDA approved. Hyoscyamine as a natural plant alkaloid derivative and anticholinergic that is used to treat mild to moderate nausea, motion sickness, hyperactive bladder and allergic rhinitis. Hyoscyamine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury. L-Hyoscyamine is a natural product found in Datura ferox, Crenidium spinescens, and other organisms with data available. Hyoscyamine is a belladonna alkaloid derivative and the levorotatory form of racemic atropine isolated from the plants Hyoscyamus niger or Atropa belladonna, which exhibits anticholinergic activity. Hyoscyamine functions as a non-selective, competitive antagonist of muscarinic receptors, thereby inhibiting the parasympathetic activities of acetylcholine on the salivary, bronchial, and sweat glands, as well as the eye, heart, bladder, and gastrointestinal tract. These inhibitory effects cause a decrease in saliva, bronchial mucus, gastric juices, and sweat. Furthermore, its inhibitory action on smooth muscle prevents bladder contraction and decreases gastrointestinal motility. The 3(S)-endo isomer of atropine. Hyoscyamine is a chemical compound, a tropane alkaloid it is the levo-isomer to atropine. It is a secondary metabolite of some plants, particularly henbane (Hyoscamus niger.). Hyoscyamine is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, pancreatitis, colic and cystitis. It has also been used to relieve some heart problems, control some of the symptoms of Parkinsons disease, as well as for control of respiratory secretions in end of life care. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BA - Belladonna alkaloids, tertiary amines C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2269 D002491 - Central Nervous System Agents KEIO_ID H045; [MS2] KO008998 KEIO_ID H045 L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2].

   

Mesembrine

(3aS,7aS)-3a-(3,4-dimethoxyphenyl)-1-methyl-2,3,4,5,7,7a-hexahydroindol-6-one

C17H23NO3 (289.1677848)


Mesembrine is a member of pyrrolidines. (-)-Mesembrine is a natural product found in Mesembryanthemum cordifolium, Oscularia deltoides, and other organisms with data available.

   

Hyoscyamine

BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER, ENDO-(+/-)-

C17H23NO3 (289.1677848)


Atropine is a racemate composed of equimolar concentrations of (S)- and (R)-atropine. It is obtained from deadly nightshade (Atropa belladonna) and other plants of the family Solanaceae. It has a role as a muscarinic antagonist, an anaesthesia adjuvant, an anti-arrhythmia drug, a mydriatic agent, a parasympatholytic, a bronchodilator agent, a plant metabolite, an antidote to sarin poisoning and a oneirogen. It contains a (S)-atropine and a (R)-atropine. Atropine is an alkaloid originally synthesized from Atropa belladonna. It is a racemic mixture of d-and l-hyoscyamine, of which only l-hyoscyamine is pharmacologically active. Atropine is generally available as a sulfate salt and can be administered by intravenous, subcutaneous, intramuscular, intraosseous, endotracheal and ophthalmic methods. Oral atropine is only available in combination products. Atropine is a competitive, reversible antagonist of muscarinic receptors that blocks the effects of acetylcholine and other choline esters. It has a variety of therapeutic applications, including pupil dilation and the treatment of anticholinergic poisoning and symptomatic bradycardia in the absence of reversible causes. Atropine is a relatively inexpensive drug and is included in the World Health Organization List of Essential Medicines. Atropine is an Anticholinergic and Cholinergic Muscarinic Antagonist. The mechanism of action of atropine is as a Cholinergic Antagonist and Cholinergic Muscarinic Antagonist. Hyoscyamine as a natural plant alkaloid derivative and anticholinergic that is used to treat mild to moderate nausea, motion sickness, hyperactive bladder and allergic rhinitis. Hyoscyamine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury. Atropine is a natural product found in Cyphanthera tasmanica, Anthocercis ilicifolia, and other organisms with data available. Atropine Sulfate is the sulfate salt of atropine, a naturally-occurring alkaloid isolated from the plant Atropa belladonna. Atropine functions as a sympathetic, competitive antagonist of muscarinic cholinergic receptors, thereby abolishing the effects of parasympathetic stimulation. This agent may induce tachycardia, inhibit secretions, and relax smooth muscles. (NCI04) Atropine is a synthetically-derived form of the endogenous alkaloid isolated from the plant Atropa belladonna. Atropine functions as a sympathetic, competitive antagonist of muscarinic cholinergic receptors, thereby abolishing the effects of parasympathetic stimulation. This agent may induce tachycardia, inhibit secretions, and relax smooth muscles. (NCI04) Hyoscyamine is a belladonna alkaloid derivative and the levorotatory form of racemic atropine isolated from the plants Hyoscyamus niger or Atropa belladonna, which exhibits anticholinergic activity. Hyoscyamine functions as a non-selective, competitive antagonist of muscarinic receptors, thereby inhibiting the parasympathetic activities of acetylcholine on the salivary, bronchial, and sweat glands, as well as the eye, heart, bladder, and gastrointestinal tract. These inhibitory effects cause a decrease in saliva, bronchial mucus, gastric juices, and sweat. Furthermore, its inhibitory action on smooth muscle prevents bladder contraction and decreases gastrointestinal motility. An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BA - Belladonna alkaloids, tertiary amines S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2292 INTERNAL_ID 2292; CONFIDENCE Reference Standard (Level 1) CONFIDENCE standard compound; EAWAG_UCHEM_ID 3334 D002491 - Central Nervous System Agents KEIO_ID A080; [MS2] KO008864 KEIO_ID A080 Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia[1][2][3][4]. Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia[1][2][3][4]. Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia[1][2][3][4]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2].

   
   

Littorine

(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) (2R)-2-hydroxy-3-phenylpropanoate

C17H23NO3 (289.1677848)


Littorine is a tropane alkaloid.

   

Lycoramine

1,2-Dihydrogalanthamine #

C17H23NO3 (289.1677848)


Lycoramine, a dihydro-derivative of galanthamine, is isolated from Lycoris radiate. Lycoramine is a potent acetylcholinesterase (AChE) inhibitor[1][2]. Lycoramine, a dihydro-derivative of galanthamine, is isolated from Lycoris radiate. Lycoramine is a potent acetylcholinesterase (AChE) inhibitor[1][2].

   

cis-1,3,4,6,7,11b-Hexahydro-9-methoxy-2H-benzo[a]quinolizine-3-carboxylic acid ethyl ester

cis-1,3,4,6,7,11b-Hexahydro-9-methoxy-2H-benzo[a]quinolizine-3-carboxylic acid ethyl ester

C17H23NO3 (289.1677848)


   

3-Ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one

3-Ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one

C17H23NO3 (289.1677848)


   

trans-1,3,4,6,7,11b-Hexahydro-9-methoxy-2H-benzo[a]quinolizine-3-carboxylic acid ethyl ester

trans-1,3,4,6,7,11b-Hexahydro-9-methoxy-2H-benzo[a]quinolizine-3-carboxylic acid ethyl ester

C17H23NO3 (289.1677848)


   

Donepezil metabolite M4

(2S,3R,4E)-2-Alkanamido-3-hydroxyoctadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2Right3)-beta-D-galactopyranoside

C17H23NO3 (289.1677848)


Donepezil metabolite M4 is a metabolite of Donepezil. Donepezil, marketed under the trade name Aricept by its developer Eisai and partner Pfizer, and also marketed under the brand name DONEP by Alkem Pentacare, is a centrally acting reversible acetylcholinesterase inhibitor. Its main therapeutic use is in the palliative treatment of Alzheimers disease. Common side effects include gastrointestinal upset. It has an oral bioavailability of 100\\% and easily crosses the blood–brain barrier. Because it has a biological half-life of about 70 hours, it can be taken once a day. (Wikipedia)

   

Dihydroferuperine

(2E,4Z)-5-(4-hydroxy-5-methoxycyclohexa-1,5-dien-1-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

C17H23NO3 (289.1677848)


Dihydroferuperine is found in herbs and spices. Dihydroferuperine is an alkaloid from pepper (Piper nigrum) (Piperaceae). Alkaloid from pepper (Piper nigrum) (Piperaceae). Dihydroferuperine is found in herbs and spices.

   

(+)-Hyoscyamine

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

C17H23NO3 (289.1677848)


Atropine, a naturally occurring belladonna alkaloid, is a racemic mixture of equal parts of d- and l-hyoscyamine, whose activity is due almost entirely to the levo isomer of the drug. Atropine is commonly classified as an anticholinergic or antiparasympathetic (parasympatholytic) drug. More precisely, however, it is termed an antimuscarinic agent since it antagonizes the muscarine-like actions of acetylcholine and other choline esters. Adequate doses of atropine abolish various types of reflex vagal cardiac slowing or asystole. The drug also prevents or abolishes bradycardia or asystole produced by injection of choline esters, anticholinesterase agents or other parasympathomimetic drugs, and cardiac arrest produced by stimulation of the vagus. Atropine may also lessen the degree of partial heart block when vagal activity is an etiologic factor. Atropine in clinical doses counteracts the peripheral dilatation and abrupt decrease in blood pressure produced by choline esters. However, when given by itself, atropine does not exert a striking or uniform effect on blood vessels or blood pressure. Atropine is found in burdock. Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia[1][2][3][4]. Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia[1][2][3][4]. Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia[1][2][3][4].

   

Dimethylphysostigmine

1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N,N-dimethylcarbamate

C16H23N3O2 (289.1790178)


   

Methylenedioxypyrrolidinohexiophenone

1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one

C17H23NO3 (289.1677848)


   

Cosmoperine

5-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)pentan-1-one

C17H23NO3 (289.1677848)


Tetrahydropiperine is a member of benzodioxoles. Tetrahydropiperine is a natural product found in Piper tuberculatum, Piper swartzianum, and Piper longum with data available. Tetrahydropiperine, a cyclohexyl analogue of piperine, is the first natural aryl pentanamide from Piper longum[1]. Tetrahydropiperine (compound 14) inhibits the cytochrome P450 (CYP) isoform CYP1A1/arylhydrocarbon hydroxylase (AHH; IC50=23 μM)[2]. Tetrahydropiperine, a cyclohexyl analogue of piperine, is the first natural aryl pentanamide from Piper longum[1]. Tetrahydropiperine (compound 14) inhibits the cytochrome P450 (CYP) isoform CYP1A1/arylhydrocarbon hydroxylase (AHH; IC50=23 μM)[2].

   
   

Isopyrodysinoic acid

(+)-Isopyrodysinoic acid

C17H23NO3 (289.1677848)


   
   

Pyrodysinoic acid

(+)-Pyrodysinoic acid

C17H23NO3 (289.1677848)


   

Pyrodysinoic acid B

Pyrodysinoic acid B

C17H23NO3 (289.1677848)


   

Methylenedioxypyrrolidinohexiophenone

Methylenedioxypyrrolidinohexiophenone

C17H23NO3 (289.1677848)


   
   

11-O-Benzoyl-4-hydroxyepilupinine

11-O-Benzoyl-4-hydroxyepilupinine

C17H23NO3 (289.1677848)


   
   
   
   

lycojaponicumin E|palcernine A

lycojaponicumin E|palcernine A

C17H23NO3 (289.1677848)


   
   

3-isopropenyl-7,7-dimethyl-8-(3-methyl-but-2-enoyl)-2,6,7,8-tetrahydro-3H-imidazo[1,2-a]pyrimidin-5-one|Alchornidin|Alchornidine

3-isopropenyl-7,7-dimethyl-8-(3-methyl-but-2-enoyl)-2,6,7,8-tetrahydro-3H-imidazo[1,2-a]pyrimidin-5-one|Alchornidin|Alchornidine

C16H23N3O2 (289.1790178)


   
   

N-5-(4-hydroxy-3-methoxyphenyl)-2E-pentenoyl piperidine

N-5-(4-hydroxy-3-methoxyphenyl)-2E-pentenoyl piperidine

C17H23NO3 (289.1677848)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Lycoramin

6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,7,8,9,10,11,12-octahydro-3-methoxy-11-methyl-, (4aS,6S,8aR)-

C17H23NO3 (289.1677848)


Lycoramine is a benzazepine. Lycoramine is a natural product found in Lycoris sanguinea, Hymenocallis rotata, and other organisms with data available. Lycoramine, a dihydro-derivative of galanthamine, is isolated from Lycoris radiate. Lycoramine is a potent acetylcholinesterase (AChE) inhibitor[1][2]. Lycoramine, a dihydro-derivative of galanthamine, is isolated from Lycoris radiate. Lycoramine is a potent acetylcholinesterase (AChE) inhibitor[1][2].

   

Atropine

BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER, ENDO-(+/-)-

C17H23NO3 (289.1677848)


Atropine is a racemate composed of equimolar concentrations of (S)- and (R)-atropine. It is obtained from deadly nightshade (Atropa belladonna) and other plants of the family Solanaceae. It has a role as a muscarinic antagonist, an anaesthesia adjuvant, an anti-arrhythmia drug, a mydriatic agent, a parasympatholytic, a bronchodilator agent, a plant metabolite, an antidote to sarin poisoning and a oneirogen. It contains a (S)-atropine and a (R)-atropine. Atropine is an alkaloid originally synthesized from Atropa belladonna. It is a racemic mixture of d-and l-hyoscyamine, of which only l-hyoscyamine is pharmacologically active. Atropine is generally available as a sulfate salt and can be administered by intravenous, subcutaneous, intramuscular, intraosseous, endotracheal and ophthalmic methods. Oral atropine is only available in combination products. Atropine is a competitive, reversible antagonist of muscarinic receptors that blocks the effects of acetylcholine and other choline esters. It has a variety of therapeutic applications, including pupil dilation and the treatment of anticholinergic poisoning and symptomatic bradycardia in the absence of reversible causes. Atropine is a relatively inexpensive drug and is included in the World Health Organization List of Essential Medicines. Atropine is an Anticholinergic and Cholinergic Muscarinic Antagonist. The mechanism of action of atropine is as a Cholinergic Antagonist and Cholinergic Muscarinic Antagonist. Hyoscyamine as a natural plant alkaloid derivative and anticholinergic that is used to treat mild to moderate nausea, motion sickness, hyperactive bladder and allergic rhinitis. Hyoscyamine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury. Atropine is a natural product found in Cyphanthera tasmanica, Anthocercis ilicifolia, and other organisms with data available. Atropine Sulfate is the sulfate salt of atropine, a naturally-occurring alkaloid isolated from the plant Atropa belladonna. Atropine functions as a sympathetic, competitive antagonist of muscarinic cholinergic receptors, thereby abolishing the effects of parasympathetic stimulation. This agent may induce tachycardia, inhibit secretions, and relax smooth muscles. (NCI04) Atropine is a synthetically-derived form of the endogenous alkaloid isolated from the plant Atropa belladonna. Atropine functions as a sympathetic, competitive antagonist of muscarinic cholinergic receptors, thereby abolishing the effects of parasympathetic stimulation. This agent may induce tachycardia, inhibit secretions, and relax smooth muscles. (NCI04) Hyoscyamine is a belladonna alkaloid derivative and the levorotatory form of racemic atropine isolated from the plants Hyoscyamus niger or Atropa belladonna, which exhibits anticholinergic activity. Hyoscyamine functions as a non-selective, competitive antagonist of muscarinic receptors, thereby inhibiting the parasympathetic activities of acetylcholine on the salivary, bronchial, and sweat glands, as well as the eye, heart, bladder, and gastrointestinal tract. These inhibitory effects cause a decrease in saliva, bronchial mucus, gastric juices, and sweat. Furthermore, its inhibitory action on smooth muscle prevents bladder contraction and decreases gastrointestinal motility. An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BA - Belladonna alkaloids, tertiary amines A racemate composed of equimolar concentrations of (S)- and (R)-atropine . It is obtained from deadly nightshade (Atropa belladonna) and other plants of the family Solanaceae. S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002491 - Central Nervous System Agents Annotation level-1 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.421 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.416 Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia[1][2][3][4]. Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia[1][2][3][4]. Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia[1][2][3][4]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2].

   

L-Hyoscyamine

Hyoscyamine (Daturine)

C17H23NO3 (289.1677848)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BA - Belladonna alkaloids, tertiary amines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002491 - Central Nervous System Agents L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2].

   

Tropan-3-yl-carboxylic acid (2-hydroxy-1-phenyl)-ethyl ester

NCGC00160291-01!Tropan-3-yl-carboxylic acid (2-hydroxy-1-phenyl)-ethyl ester

C17H23NO3 (289.1677848)


   

Hyoscyamine

BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-, (3-ENDO)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER, (.ALPHA.S)-

C17H23NO3 (289.1677848)


(S)-atropine is an atropine with a 2S-configuration. It is functionally related to a (S)-tropic acid. It is a conjugate base of a (S)-atropinium. Hyoscyamine is a tropane alkaloid and the levo-isomer of [atropine]. It is commonly extracted from plants in the Solanaceae or nightshade family. Research into the action of hyoscyamine in published literature dates back to 1826. Hyoscyamine is used for a wide variety of treatments and therapeutics due to its antimuscarinic properties. Although hyoscyamine is marketed in the United States, it is not FDA approved. Hyoscyamine as a natural plant alkaloid derivative and anticholinergic that is used to treat mild to moderate nausea, motion sickness, hyperactive bladder and allergic rhinitis. Hyoscyamine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury. L-Hyoscyamine is a natural product found in Datura ferox, Crenidium spinescens, and other organisms with data available. Hyoscyamine is a belladonna alkaloid derivative and the levorotatory form of racemic atropine isolated from the plants Hyoscyamus niger or Atropa belladonna, which exhibits anticholinergic activity. Hyoscyamine functions as a non-selective, competitive antagonist of muscarinic receptors, thereby inhibiting the parasympathetic activities of acetylcholine on the salivary, bronchial, and sweat glands, as well as the eye, heart, bladder, and gastrointestinal tract. These inhibitory effects cause a decrease in saliva, bronchial mucus, gastric juices, and sweat. Furthermore, its inhibitory action on smooth muscle prevents bladder contraction and decreases gastrointestinal motility. The 3(S)-endo isomer of atropine. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BA - Belladonna alkaloids, tertiary amines C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002491 - Central Nervous System Agents An atropine with a 2S-configuration. Annotation level-1 L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2]. L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2].

   

(1R,3S,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

(1R,3S,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

C17H23NO3 (289.1677848)


   
   
   
   
   
   
   
   
   
   
   
   
   

Dihydroferuperine

(2E,4Z)-5-(4-hydroxy-5-methoxycyclohexa-1,5-dien-1-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

C17H23NO3 (289.1677848)


   

2,3-Methylenedioxy Pyrovalerone

2,3-Methylenedioxy Pyrovalerone

C17H23NO3 (289.1677848)


   

tert-butyl 3-benzyl-4-oxopiperidine-1-carboxylate

tert-butyl 3-benzyl-4-oxopiperidine-1-carboxylate

C17H23NO3 (289.1677848)


   

1-Phenoxy-5,5-dimethyl-3-(1H-1,2,4-triazol-1-yl)-4-hexanol

1-Phenoxy-5,5-dimethyl-3-(1H-1,2,4-triazol-1-yl)-4-hexanol

C16H23N3O2 (289.1790178)


   

BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE

BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE

C16H23N3O2 (289.1790178)


   

1-λ1-oxidanyl-2,2,5,5-tetramethyl-N-(1,3,4-trihydroxybutan-2-yl)pyrrolidine-3-carboxamide

1-λ1-oxidanyl-2,2,5,5-tetramethyl-N-(1,3,4-trihydroxybutan-2-yl)pyrrolidine-3-carboxamide

C13H25N2O5 (289.176338)


   

N-Acetyl-3-(4-(p-methoxyphenyl)piperazinyl)azetidine

N-Acetyl-3-(4-(p-methoxyphenyl)piperazinyl)azetidine

C16H23N3O2 (289.1790178)


   

(S)-4-BENZYL-3-HEPTANOYLOXAZOLIDIN-2-ONE

(S)-4-BENZYL-3-HEPTANOYLOXAZOLIDIN-2-ONE

C17H23NO3 (289.1677848)


   

tert-butyl 4-benzoylpiperidine-1-carboxylate

tert-butyl 4-benzoylpiperidine-1-carboxylate

C17H23NO3 (289.1677848)


   

2-methylpiperidine; 2-methylpiperidine-1-carbodithioic acid

2-methylpiperidine; 2-methylpiperidine-1-carbodithioic acid

C13H27N3S2 (289.1646302)


   

Rotraxate

Rotraxate

C17H23NO3 (289.1677848)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent

   

tert-Butyl 2-benzyl-4-oxopiperidine-1-carboxylate

tert-Butyl 2-benzyl-4-oxopiperidine-1-carboxylate

C17H23NO3 (289.1677848)


   

(1-PIPERIDIN-4-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

(1-PIPERIDIN-4-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

C16H23N3O2 (289.1790178)


   

(1-PIPERIDIN-3-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

(1-PIPERIDIN-3-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

C16H23N3O2 (289.1790178)


   

benzyl N-[(1-pyrrolidin-3-ylazetidin-3-yl)methyl]carbamate

benzyl N-[(1-pyrrolidin-3-ylazetidin-3-yl)methyl]carbamate

C16H23N3O2 (289.1790178)


   
   

L-Alanine, L-leucyl-L-seryl-

L-Alanine, L-leucyl-L-seryl-

C12H23N3O5 (289.1637628)


   
   

Pharmakon1600-01500346

Pharmakon1600-01500346

C17H23NO3 (289.1677848)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BA - Belladonna alkaloids, tertiary amines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002491 - Central Nervous System Agents

   

Leu-Ala-Ser

Leu-Ala-Ser

C12H23N3O5 (289.1637628)


A tripeptide composed of L-leucine, L-alanine and L-serine joined in sequence by peptide linkages.

   
   

3-Methyl-4-oxo-1,5,6,7-tetrahydroindole-2-carboxylic acid (4-methylcyclohexyl) ester

3-Methyl-4-oxo-1,5,6,7-tetrahydroindole-2-carboxylic acid (4-methylcyclohexyl) ester

C17H23NO3 (289.1677848)


   

(2S)-3-hydroxy-2-phenylpropanoic acid [(1R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

(2S)-3-hydroxy-2-phenylpropanoic acid [(1R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

C17H23NO3 (289.1677848)


   
   
   
   
   
   
   
   
   
   

2,6-Bis(2-furanyl)-4-methyl-3-propyl-4-piperidinol

2,6-Bis(2-furanyl)-4-methyl-3-propyl-4-piperidinol

C17H23NO3 (289.1677848)


   
   

(1S,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.1790178)


   

(1S,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.1790178)


   

(1R,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.1790178)


   

(1R,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.1790178)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(Z)-11-methyl-N-(methylsulfonyl)dodec-2-enamide

(Z)-11-methyl-N-(methylsulfonyl)dodec-2-enamide

C14H27NO3S (289.17115520000004)


   

8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octanoate

8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octanoate

C14H25O6- (289.16510500000004)


   

(7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoctanoate

(7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoctanoate

C14H25O6- (289.16510500000004)


   

(2-hydroxy-1-phenylethyl) (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octane-3-carboxylate

(2-hydroxy-1-phenylethyl) (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octane-3-carboxylate

C17H23NO3 (289.1677848)


   

(6-Methyl-6-azabicyclo[3.1.1]heptan-3-yl)methyl 3-hydroxy-2-phenylpropanoate

(6-Methyl-6-azabicyclo[3.1.1]heptan-3-yl)methyl 3-hydroxy-2-phenylpropanoate

C17H23NO3 (289.1677848)


   

3-hydroxy-2-phenylpropanoic acid (8-methyl-8-azabicyclo[3.2.1]octan-3-yl) ester

3-hydroxy-2-phenylpropanoic acid (8-methyl-8-azabicyclo[3.2.1]octan-3-yl) ester

C17H23NO3 (289.1677848)


   

5,6-Dimethoxy-2-(piperidin-4-yl)methylene-indan-1-one

5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one

C17H23NO3 (289.1677848)


   

(R)-atropine

(R)-atropine

C17H23NO3 (289.1677848)


An atropine with a 2R-configuration.

   

oscr#14(1-)

oscr#14(1-)

C14H25O6 (289.16510500000004)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#14, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(2S)-3-hydroxy-2-phenylpropanoic acid [(5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

(2S)-3-hydroxy-2-phenylpropanoic acid [(5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

C17H23NO3 (289.1677848)


   

(2S)-3-hydroxy-2-phenylpropanoic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

(2S)-3-hydroxy-2-phenylpropanoic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

C17H23NO3 (289.1677848)


   

ascr#14(1-)

ascr#14(1-)

C14H25O6 (289.16510500000004)


Conjugate base of ascr#14

   

tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate

tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate

C17H23NO3 (289.1677848)


A tropane alkaloid that is (1R,5)-8-methyl-8-azabicyclo[3.2.1]octane substituted by a (3-hydroxy-2-phenylpropanoyl)oxy group at position 3.

   
   

8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-3-hydroxy-2-phenylpropanoate

8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-3-hydroxy-2-phenylpropanoate

C17H23NO3 (289.1677848)


   

10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-triene-4,11'-diol

10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-triene-4,11'-diol

C17H23NO3 (289.1677848)


   

(2r,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-carboximidic acid

(2r,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-carboximidic acid

C17H23NO3 (289.1677848)


   

(3ar,6r,7as)-3a-(3,4-dimethoxyphenyl)-1-methyl-3,6,7,7a-tetrahydro-2h-indol-6-ol

(3ar,6r,7as)-3a-(3,4-dimethoxyphenyl)-1-methyl-3,6,7,7a-tetrahydro-2h-indol-6-ol

C17H23NO3 (289.1677848)


   

(3as,7as)-3a-(3,4-dimethoxyphenyl)-1-methyl-hexahydroindol-6-one

(3as,7as)-3a-(3,4-dimethoxyphenyl)-1-methyl-hexahydroindol-6-one

C17H23NO3 (289.1677848)


   

2,3-dihydroxy-3-octylquinolin-4-one

2,3-dihydroxy-3-octylquinolin-4-one

C17H23NO3 (289.1677848)


   

5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)pent-2-en-1-one

5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)pent-2-en-1-one

C17H23NO3 (289.1677848)


   

7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

C16H23N3O2 (289.1790178)


   

3a-(3,4-dimethoxyphenyl)-1-methyl-3,6,7,7a-tetrahydro-2h-indol-6-ol

3a-(3,4-dimethoxyphenyl)-1-methyl-3,6,7,7a-tetrahydro-2h-indol-6-ol

C17H23NO3 (289.1677848)


   

3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-carboximidic acid

3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-carboximidic acid

C17H23NO3 (289.1677848)


   

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-14-ol

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-14-ol

C17H23NO3 (289.1677848)


   

{4,4,7-trimethyl-2-oxo-4ah,5h,6h,8ah,9h,9ah-cyclohexa[f]indol-1-yl}acetic acid

{4,4,7-trimethyl-2-oxo-4ah,5h,6h,8ah,9h,9ah-cyclohexa[f]indol-1-yl}acetic acid

C17H23NO3 (289.1677848)


   

(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-2-hydroxy-3-phenylpropanoate

(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-2-hydroxy-3-phenylpropanoate

C17H23NO3 (289.1677848)


   

(3r)-7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

(3r)-7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

C16H23N3O2 (289.1790178)


   

(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-3-hydroxy-2-phenylpropanoate

(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-3-hydroxy-2-phenylpropanoate

C17H23NO3 (289.1677848)


   

{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}(4,5-dihydroxypiperidin-2-yl)acetic acid

{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}(4,5-dihydroxypiperidin-2-yl)acetic acid

C12H23N3O5 (289.1637628)


   

(1s,2s,3r,5s,7r)-2-benzyl-7-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

(1s,2s,3r,5s,7r)-2-benzyl-7-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

C17H23NO3 (289.1677848)


   

[(2-amino-1-hydroxy-3-methylbutylidene)amino](4,5-dihydroxypiperidin-2-yl)acetic acid

[(2-amino-1-hydroxy-3-methylbutylidene)amino](4,5-dihydroxypiperidin-2-yl)acetic acid

C12H23N3O5 (289.1637628)


   

(3ar,6s,7as)-3a-(3,4-dimethoxyphenyl)-1-methyl-3,6,7,7a-tetrahydro-2h-indol-6-ol

(3ar,6s,7as)-3a-(3,4-dimethoxyphenyl)-1-methyl-3,6,7,7a-tetrahydro-2h-indol-6-ol

C17H23NO3 (289.1677848)


   

[(4as,8ar,9as)-6,9,9-trimethyl-2-oxo-4h,4ah,7h,8h,8ah,9ah-cyclohexa[f]indol-1-yl]acetic acid

[(4as,8ar,9as)-6,9,9-trimethyl-2-oxo-4h,4ah,7h,8h,8ah,9ah-cyclohexa[f]indol-1-yl]acetic acid

C17H23NO3 (289.1677848)


   

(3as)-3a-(3,4-dimethoxyphenyl)-1-methyl-hexahydroindol-6-one

(3as)-3a-(3,4-dimethoxyphenyl)-1-methyl-hexahydroindol-6-one

C17H23NO3 (289.1677848)


   

[(4ar,8ar,9as)-4,4,7-trimethyl-2-oxo-4ah,5h,6h,8ah,9h,9ah-cyclohexa[f]indol-1-yl]acetic acid

[(4ar,8ar,9as)-4,4,7-trimethyl-2-oxo-4ah,5h,6h,8ah,9h,9ah-cyclohexa[f]indol-1-yl]acetic acid

C17H23NO3 (289.1677848)


   

[(4ar,8ar,9ar)-6,9,9-trimethyl-2-oxo-4h,4ah,7h,8h,8ah,9ah-cyclohexa[f]indol-1-yl]acetic acid

[(4ar,8ar,9ar)-6,9,9-trimethyl-2-oxo-4h,4ah,7h,8h,8ah,9ah-cyclohexa[f]indol-1-yl]acetic acid

C17H23NO3 (289.1677848)


   

(2r)-2-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-2,3-dihydro-1h-indole-5-carboxylic acid

(2r)-2-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-2,3-dihydro-1h-indole-5-carboxylic acid

C17H23NO3 (289.1677848)


   

3a-(3,4-dimethoxyphenyl)-1-methyl-hexahydroindol-6-one

3a-(3,4-dimethoxyphenyl)-1-methyl-hexahydroindol-6-one

C17H23NO3 (289.1677848)


   

2-benzyl-7-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

2-benzyl-7-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

C17H23NO3 (289.1677848)


   

(1r,3s,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-2-hydroxy-3-phenylpropanoate

(1r,3s,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-2-hydroxy-3-phenylpropanoate

C17H23NO3 (289.1677848)


   

(1r,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-14-ol

(1r,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-14-ol

C17H23NO3 (289.1677848)


   

2-(2-hydroxy-6-methylhept-5-en-2-yl)-2,3-dihydro-1h-indole-5-carboxylic acid

2-(2-hydroxy-6-methylhept-5-en-2-yl)-2,3-dihydro-1h-indole-5-carboxylic acid

C17H23NO3 (289.1677848)


   

methyl 8-hydroxy-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadeca-2,4-diene-4-carboxylate

methyl 8-hydroxy-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadeca-2,4-diene-4-carboxylate

C17H23NO3 (289.1677848)


   

hyoscyamine, its salts and derivatives

hyoscyamine, its salts and derivatives

C17H23NO3 (289.1677848)


   

methyl (1s,6r,8s,9s)-8-hydroxy-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadeca-2,4-diene-4-carboxylate

methyl (1s,6r,8s,9s)-8-hydroxy-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadeca-2,4-diene-4-carboxylate

C17H23NO3 (289.1677848)


   

{6,9,9-trimethyl-2-oxo-4h,4ah,7h,8h,8ah,9ah-cyclohexa[f]indol-1-yl}acetic acid

{6,9,9-trimethyl-2-oxo-4h,4ah,7h,8h,8ah,9ah-cyclohexa[f]indol-1-yl}acetic acid

C17H23NO3 (289.1677848)


   
   

(2s,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-carboximidic acid

(2s,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-carboximidic acid

C17H23NO3 (289.1677848)


   

(1r,2r,3r,5s)-2-[(s)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

(1r,2r,3r,5s)-2-[(s)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

C17H23NO3 (289.1677848)


   

(1s,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

(1s,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H23NO3 (289.1677848)


   

(2e)-5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)pent-2-en-1-one

(2e)-5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)pent-2-en-1-one

C17H23NO3 (289.1677848)


   

2-[hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

2-[hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

C17H23NO3 (289.1677848)


   

[(4ar,8as,9as)-6,9,9-trimethyl-2-oxo-4h,4ah,7h,8h,8ah,9ah-cyclohexa[f]indol-1-yl]acetic acid

[(4ar,8as,9as)-6,9,9-trimethyl-2-oxo-4h,4ah,7h,8h,8ah,9ah-cyclohexa[f]indol-1-yl]acetic acid

C17H23NO3 (289.1677848)